YATHARTH

1 deep-dive · 1 policy note

Deep-dive research

YATHARTH:NSE2026-10-08

Yatharth Hospital & Trauma Care Services — Deep Dive Analysis

Revenue up 52% but net profit flat for five straight quarters as depreciation and interest consume the growth. Advent International is buying 24.87% at Rs 985 - diluting EPS by up to 25% versus the published consensus. The market price sits above both the average analyst target and Advent's own entry price. Rating: CAUTION - wait for dips.

deep-divefundamentalhospitalshealthcareprivate-equity

Mentioned in Policy Pulse

HDFCBANK:ICICIBANK:SBIN:KOTAKBANK:AXISBANK:BAJFINANCE:CHOLAFIN:SHRIRAMFIN:PFC:RECLTD:IREDA:HUDCO:DLF:OBEROIRLTY:CRISIL:ICRA:BSE:CDSL:ANGELONE:MOTILALOFS:IIFL:APOLLOHOSP:FORTIS:MAXHEALTH:MEDANTA:KIMS:YATHARTH:HCG:SUNPHARMA:CIPLA:DRREDDY:LUPIN:NIBE:BDL:HAL:BEL:DATAPATTNS:PARAS:SOLARINDS:MAZDOCK:COCHINSHIP:BEML:MTARTECH:ASTRAMICRO:IDEAFORGE:ZENTEC:TCS:INFY:HCLTECH:WIPRO:TECHM:COFORGE:PERSISTENT:LTM2026-10-09

Policy Pulse - Ministries & Regulators - 09 Oct 2026

The RBI raised daily CRR maintenance to 99% and lined up Rs 25,000 crore of bond sales, negative for rate-sensitive NBFCs and bond-funded lenders; SEBI mandated a colour-coded credit risk-o-meter, positive for CRISIL and ICRA; and a 30% cap on cancer-drug trade margins lifted Apollo Hospitals and Fortis while TCS led a 3% Nifty IT rally.

policy-pulserbisebiregulationpharma